First Lady Jill Biden discussed the HICCC’s ongoing work in addressing health inequities and breaking down barriers to state-of-the-art care, including access to cancer clinical trials. She shared the story of Mario Sambula, a patient enrolled in a clinical trial at the HICCC, and how his care team and clinical trials nurse navigator, Brianne Bodin, B.S.N,, R.N., has helped guide him each step of the way.
“It’s stories like [Mario’s], about putting patients in the center of their care, that make the Columbia Cancer Center so special,” she said. “This cancer center is addressing the deep disparities in care that we’ve seen just far too often. When it comes to clinical trials, too many people get left behind but this cancer center is changing that.”
Sambula, 85, from Bronx, N.Y., shared his experience with the First Lady and the Queen. Sambula, who came to the U.S. from Honduras when he was 25, was diagnosed with prostate cancer shortly after his retirement in 2002 as a fabric cutter in New York City’s garment district. After his cancer diagnosis, he completed treatment and felt well, but a few years later, the cancer returned and had spread. Faced with few options for treatment, Sambula enrolled in a cancer clinical trial at Columbia, which stabilized his disease, now four years and counting.
Dr. Biden and Queen Letizia, who serves as Honorary President of the Spanish Association Against Cancer, share an interest in and commitment to fighting cancer.
Queen Letizia emphasized the importance of prevention. “Prevention is more effective than any cure and the most cost effective cancer control strategy in the long term.”
The visit with the HICCC included meetings with Columbia cancer researchers co-leading global collaborations, with partnerships in Spain and the Dominican Republic.
Dr. Raul Rabadan, Ph.D., professor of systems biology and of biomedical informatics at VP&S, discussed his collaboration with the Spanish National Cancer Research Centre (CNIO), to apply computational approaches to identify high-risk factors for pancreatic cancer, a project supported by Stand Up to Cancer and Lustgarten Foundation. Dr. Chin Hur, M.D., professor of medicine, who specializes in cancer screening and prevention for gastrointestinal cancers, shared details about the HICCC’s partnership with several hospitals in the Dominican Republic to address the increasing rates of cancer deaths in that country. Dr. Hur is also a gastroenterologist at NewYork-Presbyterian/Columbia.
The First Lady and the Queen also met with Dr. Mary Beth Terry, Ph.D., professor at Columbia’s Mailman School of Public Health, who leads community engagement and outreach for the HICCC. Dr. Terry showcased the cancer center’s National Cancer Institute-funded YES in the Heights Program, a summer internship for high school and undergraduate students that aims to increase the pool of underrepresented and under-resourced youth entering STEM fields. Before their remarks, the First Lady and the Queen surprised a group of high school and undergraduate students, from across the five boroughs, who have all participated in YES.
The problem of underrepresentation and lack of diversity in clinical trials was another topic of discussion for Dr. Biden and Queen Letizia on their Columbia tour. Speaking to Dr. Andrew Lassman, M.D., associate dean of clinical trials at Columbia and chief of neuro-oncology at NewYork-Presbyterian/Columbia, they learned about the HICCC’s efforts to increase the participation of underrepresented groups in clinical trials and among clinical researchers. They discussed the importance of diversity among clinical trial participants as a critical step toward reducing racial and ethnic health disparities.
Bodin, who is patient Sambula’s nurse navigator and oncology research nurse manager in the HICCC’s Clinical Trials Office, emphasized the critical role nurse navigators play in healthcare and in helping to ensure the research at the cancer center is representative of its community.
“We aim to make the process of finding and enrolling in a clinical trial as seamless as possible, while also being a source of compassionate, human connection that patients need and deserve,” said Bodin.
Today’s visit echoed President Joe Biden’s expansion of Cancer Moonshot, with new goals set to reduce the death rate from cancer by at least 50 percent over the next 25 years, and improve the experience of people and their families living with and surviving cancer.
Recognizing this as an ambitious goal, Dr. Biden said, “None of us can beat cancer alone. It takes all of us, sharing our best ideas and practices, working together to ease the burden on patients and their families, and creating the kind of care that saves lives … Together, we can give our people the future they deserve, no matter where they call home.”